Current therapeutic uses of lenalidomide in multiple myeloma

Author： Hideshima Teru Richardson Paul G Anderson Kenneth C

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.2, 2006-02, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lenalidomide delays multiple myeloma progression

Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma

By Shah Sachin R.

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1869-1881

Adis International

Access to resources Recommend Favorite

Lenalidomide: A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma

By Scott Lesley J. Lyseng-Williamson Katherine A.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 625-649

Adis International

Access to resources Recommend Favorite

Antiangiogenic Therapeutic Approaches in Multiple Myeloma

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 768-775

Bentham Science Publishers

Access to resources Recommend Favorite

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 155-167

Bentham Science Publishers

Access to resources Recommend Favorite